HHHafid Hachri

Hafid Hachri

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hafid Hachri has a total of 58 co-authors. Here are the top co-authors by number of shared publications:

  • Maryam Bigdeli

    Research Centre on Health Policies and Systems - International Health (Polissi), School of Public Health, Université Libre de Bruxelles, Brussels, Belgium

    2 shared publications
  • Abdelouahab Belmadani

    Ministry of Health, Directorate of Planning of Financial Resources, 335, Avenue Mohamed V, Rabat, Morocco

    1 shared publication
  • Abdullahi Abdulle Ali

    Capital University of Somalia, Mogadishu, Somalia

    1 shared publication
  • Afrah

    Federal Ministry of Health Somalia, Mogadishu, Somalia

    1 shared publication
  • Anas Ahmed Mountassir

    Laboratory of Community Health, Preventive Medicine and Hygiene, Laboratory of Biostatistics, Clinical Research and Epidemiology, University Mohammed V in Rabat

    1 shared publication
  • Antia Castedo

    Family, Health Promotion and Life Course, Regional Office for the Americas/Pan American Health Organization, Washington, USA

    1 shared publication

Latest Publications

  • Open Access

    Prevalence of psychoactive substance use among medical students in the EMRO region

    by Nada Bennani Mechita, Anas Ahmed Mountassir, Sara Messaoud, Karim Sbai Idrissi, Hafid Hachri, Khalid Saeed, Rachid Razine, Majdouline Obtel

    Background: The use of psychoactive substances is a growing global public health concern because of its high prevalence and associated risks of morbidity and mortality. In the Eastern Mediterranean Region (EMRO), this issue is particularly pressing among medical students, as it can impact their academic performance, mental health and future professional behaviour.Aim: This systematic review and meta-analysis aim to determine the prevalence and patterns of psychoactive substance use among medical students in the EMRO region.Setting: Studies conducted in the EMRO region were included in the analysis.Method: A systematic search was conducted in PubMed, Scopus and Web of Science, identifying eligible studies. A random-effects model was used to estimate pooled prevalence rates, and meta-regression was performed to assess factors influencing prevalence variation.Results: Ten studies were included in the study. The pooled prevalence of alcohol consumption among medical students was 9.52% (95% confidence interval [CI]: [4.82–17.93]), which decreased to 5.92% (95% CI: [4.59–7.60]) after removing outliers (I2 = 81.3%). Meta-regression indicated that studies with sample sizes above 500 reported lower prevalence than smaller studies (β = –1.55, 95% CI: [–2.89; –0.21]). The pooled prevalence of illicit drug use was 9.89% (95% CI: [4.67–19.75]) and 7.78% (95% CI: [3.71–15.58]) after outlier removal.Conclusion: Substance use among medical students in the EMRO region remains a significant concern.Contribution: This study highlights the urgent need for preventive strategies to raise awareness and promote healthier behaviours among medical students.


  • Open Access

    Action on the social determinants for advancing health equity in the time of COVID-19: perspectives of actors engaged in a WHO Special Initiative

    by Orielle Solar, Nicole Valentine, Antia Castedo, Gonzalo Soto Brandt, Jaitra Sathyandran, Zahra Ahmed, Paul Cheh, Emma Callon, Felicity Porritt, Isabel Espinosa, et al.

    Since the 2008 publication of the reports of the Commission on Social Determinants of Health and its nine knowledge networks, substantial research has been undertaken to document and describe health inequities. The COVID-19 pandemic has underscored the need for a deeper understanding of, and broader action on, the social determinants of health. Building on this unique and critical opportunity, the World Health Organization is steering a multi-country Initiative to reduce health inequities through an action-learning process in ‘Pathfinder’ countries. The Initiative aims to develop replicable and reliable models and practices that can be adopted by WHO offices and UN staff to address the social determinants of health to advance health equity. This paper provides an overview of the Initiative by describing its broad theory of change and work undertaken in three regions and six Pathfinder countries in its first year-and-a-half. Participants engaged in the Initiative describe results of early country dialogues and promising entry points for implementation that involve model, network and capacity building. The insights communicated through this note from the field will be of interest for others aiming to advance health equity through taking action on the social determinants of health, in particular as regards structural determinants.


  • Open Access

    Benefit-risk analysis of maintaining essential Reproductive, Maternal, Newborn, and Child Health (RMNCH) services against risk of COVID-19 infection

    by Eva Weissman, Denise Buchner, Nilmini Hemachandra, Khalid Siddeeg, Mohammad Samim Soroush, Ahmed Javed Rahmanzai, Paata Chikvaidze, Zaid Muayad Yassen, Hanan Hasan, Mohamed Berraho, et al.

    With the COVID-19 pandemic spreading across the world, its disruptive effect on the provision and utilization of non- COVID related health services have become well-documented. As countries developed mitigation strategies to help continue the delivery of essential health services through the pandemic, they needed to carefully weigh the benefits and risks of pursuing these strategies. In an attempt to assist countries in their mitigation efforts, a Benefit-Risk model was designed to provide guidance on how to compare the health benefits of sustained essential reproductive, maternal, newborn and child (RMNCH) services against the risk of SARS-CoV-2 infections incurred by the countries’ populations when accessing these services. This article describes how two existing models were combined to create this model, the field-testing process carried out from November 2020 through March 2021 in six countries and the findings. The overall Benefit-Risk Ratio in the 6 countries analyzed was found to be between 13.7 and 79.2, which means that for every 13.7 to 79.2 lives gained due to increased RMNCH service coverage, there was one loss of a life related to COVID-19. In all cases and for all services, the benefit of maintaining essential health services far exceeded the risks associated with additional COVID-19 infections and deaths. This modelling process illustrated how essential health services can continue to operate during a pandemic and how mitigation measures can reduce COVID-19 infections and restore or increase coverage of essential health services. Overall, this Benefit-Risk analysis underscored the importance and value of maintaining coverage of essential health services even during public health emergencies, including the recent COVID-19 pandemic


  • Open Access

    Policy dialogue and participation: a new way of crafting a national health financing strategy in Morocco

    by El Houcine Akhnif, Hafid Hachri, Abdelouahab Belmadani, Awad Mataria, Maryam Bigdeli

    Background: Policy dialogue for health policies has started to gain importance in recent years, especially for complex issues such as health financing. Moroccan health financing has faced several challenges during the last years. This study aims to document the Moroccan experience in developing a consolidated health financing strategy according to the policy dialogue approach. It especially considers the importance of conceptualising this process in the Moroccan context. Method: We documented the process of developing a health financing strategy in Morocco. It concerned four steps, as follows: (1) summarising health financing evidence in preparation of the policy dialogue; (2) organising the health policy dialogue process with 250 participants (government, private sector, NGOs, civil society, parliamentarians, technical and financial partners); (3) a technical workshop to formulate the strategy actions; and (4) an ultimate workshop for validation with decision-makers. The process lasted 1 year from March 2019 to February 2020. We have reviewed all documents related to the four steps of the process through our active participation in the policy debate and the documentation of two technical workshops to produce the strategy document. Results: The policy dialogue approach showed its usefulness in creating convergence among all health actors to define a national shared vision on health financing in Morocco. There was a high political commitment in the process and all actors officially adopted recommendations on health financing actions. A strategy document produced within a collaborative approach was the final output. This experience also marked a shift from previous top-down approaches in designing health policies for more participation and inclusion. The evidence synthesis played a crucial role in facilitating the debate. The collaborative approach seems to work in favouring national consensus on practical health financing actions. Conclusion: The policy dialogue process adopted for health financing in Morocco helped to create collective ownership of health financing actions. Despite the positive results in terms of national mobilisation around the health financing vision in Morocco, there is a need to institutionalise the policy dialogue with a more decentralised approach to consider subnational specificities.